Researchers at the RIKEN Advanced Science Institute have demonstrated that a technique for tagging and profiling proteins can be used to accurately classify anti-cancer drugs based on the molecules they target. The technique, developed in collaboration with a researcher at the University of Tsukuba, promises to accelerate the process of proteomic profiling and contribute to more effective drug discovery.
While essential for effective treatment, our understanding of the complex relationship between drugs and their molecular targets is far from complete. Drug efficacy is thus low, and drugs are often accompanied by dangerous side effects. Targeted cancer therapies, which act by interfering with specific molecules contributing to tumor growth, can bring therapeutic benefits to certain patients, yet are not free of these problems. Solving them depends on connecting drugs to their molecular targets, a task complicated by the huge variety of proteins and complexity of drug-target networks.
In recent years, the field of proteomics has produced powerful techniques that simplify this task by accurately identifying proteins and their interactions. The research team used one of these techniques, two-dimensional difference gel electrophoresis (2D-DIGE), to analyze and compare changes of protein expression levels in HeLa cancer cells treated with 19 well-known anti-cancer agents. The method successfully classified compounds of different structures but sharing molecular target(s), while revealing that compounds previously reported to inhibit the same process in fact were clustered into different groups, highlighting differences in underlying interaction mechanisms.
Described in the journal Chemistry and Biology, the findings broaden the scope of proteomic profiling by enabling researchers to characterize specific compounds in terms of how they interact with biomolecules. While refining the drug discovery process, this advance also contributes to minimizing side-effects, potentially supporting the future development of safer and more effective anticancer drugs.
For more information, please contact:Dr. Hiroyuki Osada
'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology
Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University
Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
23.10.2017 | Event News
17.10.2017 | Event News
10.10.2017 | Event News
23.10.2017 | Life Sciences
23.10.2017 | Physics and Astronomy
23.10.2017 | Health and Medicine